Intelligence Platform

Patents

Browse 67 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9095608

Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD

The Regents of the University of Colorado · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8450299

Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

Teva Womans's Health, Inc. · Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8415332

Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

Teva Womans's Health, Inc. · Granted Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8361471

Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD

The Regents of the University of Colorado · Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8137672

Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD

The Regents of the University of Colorado · Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7993648

Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD

The Regents of the University of Colorado · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7855190

Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen ad

TEVA WOMEN'S HEALTH, INC. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7772219

Methods of hormonal treatment utilizing extended cycle contraceptive regimens

TEVA WOMEN'S HEALTH, INC. · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7541331

Surfactant treatment regimen

Discovery Laboratories, Inc. · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6759408

Combination regimens using progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Tue Jul 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6544970

Cyclic regimens utilizing indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Apr 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6503939

Combination regimens using 3,3-substituted indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Jan 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6498154

Cyclic regimens using quinazolinone and benzoxazine derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Dec 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6462032

Cyclic regimens utilizing indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Oct 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6444668

Combination regimens using progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Tue Sep 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6399593

Cyclic regimens using cyclic urea and cyclic amide derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Jun 04 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6380178

Cyclic regimens using cyclocarbamate and cyclic amide derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Apr 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6329416

Combination regimens using 3,3-substituted indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Dec 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6319912

Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides

Ligand Pharmaceuticals Incorporated · Granted Tue Nov 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired